Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

7.370
+0.4506.50%
Volume:160.30M
Turnover:1.17B
Market Cap:138.27B
PE:35.19
High:7.430
Open:7.000
Low:6.970
Close:6.920
52wk High:9.120
52wk Low:2.634
Shares:18.76B
HK Float Shares:18.76B
Volume Ratio:2.55
T/O Rate:0.85%
Dividend:0.09
Dividend Rate:1.23%
EPS(LYR):0.209
ROE:15.40%
ROA:5.07%
PB:3.78
PE(LYR):35.19
PS:4.13

Loading ...

Sino Biopharmaceutical Stock Slips 5.4% in Hong Kong

Dow Jones
·
Oct 14

GF Securities Initiates Coverage on Sino Biopharm (01177) with "Buy" Rating, Entering New Stage of Innovation Development

Stock News
·
Oct 14

Sino Biopharmaceutical's Colorectal Cancer Drug Receives Breakthrough Therapeutic Designation in China

MT Newswires Live
·
Oct 14

BRIEF-Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In China

Reuters
·
Oct 13

SINO BIOPHARM (01177): TQB2102 "HER2 Bispecific ADC" Granted Breakthrough Therapy Designation

Stock News
·
Oct 13

Sino Biopharmaceutical - Tqb2102 Included in Breakthrough Therapeutic Designation Process in China

THOMSON REUTERS
·
Oct 13

CMB International Maintains SINO BIOPHARM (01177) Target Price at HK$9.4 with "Buy" Rating

Stock News
·
Oct 13

Sino Biopharmaceutical Stock Slips 1.3% in Hong Kong

Dow Jones
·
Oct 10

CICC: Optimistic About Long-term Development Trends in Innovative Pharmaceuticals, Anticipates Commercial Insurance Breakthrough

Stock News
·
Oct 09

Hong Kong Stock Market Analysis | National Day Holiday Brings Mixed Signals as Gold Continues Safe-Haven Rally, US Giants Double Down on AI Collaboration

Stock News
·
Oct 08

Sino Biopharmaceutical Stock Climbs 2.9% in Hong Kong, Outperforms Competitors

Dow Jones
·
Oct 08

Advancing Oral GLP-1 and Oncology Trials Might Change The Case For Investing In Sino Biopharm (SEHK:1177)

Simply Wall St.
·
Oct 07

Sino Biopharmaceutical Stock Slips 1.1% in Hong Kong

Dow Jones
·
Oct 06

Sino Biopharmaceutical Stock Climbs 2.6% in Hong Kong

Dow Jones
·
Oct 02

GTHT Initiates Coverage on SINO BIOPHARM with "Buy" Rating, Sets HK$10 Target Price

Stock News
·
Sep 30

Sino Biopharmaceutical Stock Rises 1.0% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 30

China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 30

The three-year decline in earnings might be taking its toll on Sino Biopharmaceutical (HKG:1177) shareholders as stock falls 6.0% over the past week

Simply Wall St.
·
Sep 28

Sino Biopharmaceutical Limited Reports 27.2% Increase in Innovative Product Sales and Significant Year-on-Year Profit Growth for First Half of 2025

Reuters
·
Sep 26

Sino Biopharm Completes First Patient Enrollment of Anti-Tumor Drug Trial in Australia

MT Newswires Live
·
Sep 25